Market Cap

$12.4B

Volume

1.9M

Cash and Equivalents

$675.4M

EBITDA

$426.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.4B

Profit Margin

52.35%

52 Week High

$99.56

52 Week Low

$61.15

Dividend

N/A

Price / Book Value

2.29

Price / Earnings

38.71

Price / Tangible Book Value

2.50

Enterprise Value

$12.1B

Enterprise Value / EBITDA

27.38

Operating Income

$326.4M

Return on Equity

6.25%

Return on Assets

3.00

Cash and Short Term Investments

$930.4M

Debt

$602.7M

Equity

$5.4B

Revenue

$2.8B

Unlevered FCF

$154.8M

Sector

Biotechnology

Category

N/A